These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20308653)
21. The EWS protein is dispensable for Ewing tumor growth. Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040 [TBL] [Abstract][Full Text] [Related]
22. RE: local control in nonmetastatic pelvic Ewing's sarcoma patients: Outcome and analysis, by Donati, D, et al. Hornicek FJ J Surg Oncol; 2007 Nov; 96(6):453-4. PubMed ID: 17654523 [No Abstract] [Full Text] [Related]
23. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476 [TBL] [Abstract][Full Text] [Related]
24. Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction. Mangham DC; Williams A; McMullan DJ; McClure J; Sumathi VP; Grimer RJ; Davies AM Histopathology; 2006 Mar; 48(4):363-76. PubMed ID: 16487358 [TBL] [Abstract][Full Text] [Related]
25. Arrangement of chromosome 11 and 22 territories, EWSR1 and FLI1 genes, and other genetic elements of these chromosomes in human lymphocytes and Ewing sarcoma cells. Taslerová R; Kozubek S; Lukásová E; Jirsová P; Bártová E; Kozubek M Hum Genet; 2003 Feb; 112(2):143-55. PubMed ID: 12522555 [TBL] [Abstract][Full Text] [Related]
26. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors. Burdach S; Nürnberger W; Laws HJ; Engel BC; Dirksen U; Krauth K; Pape H; Kahn T; Körholz D; Gadner H; Göbel U; Jürgens H Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S67-8. PubMed ID: 8899179 [No Abstract] [Full Text] [Related]
27. A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R Eur J Surg Oncol; 2001 Sep; 27(6):569-73. PubMed ID: 11520091 [TBL] [Abstract][Full Text] [Related]
28. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454 [TBL] [Abstract][Full Text] [Related]
29. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents]. Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509 [TBL] [Abstract][Full Text] [Related]
30. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669 [TBL] [Abstract][Full Text] [Related]
31. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313 [TBL] [Abstract][Full Text] [Related]
32. [Ewing's sarcoma in childhood: the therapeutic results]. Madero L; Muñoz A; Lorenzo G; Amaya J; Alonso MA; Durán R Med Clin (Barc); 1990 Oct; 95(13):486-9. PubMed ID: 2084425 [TBL] [Abstract][Full Text] [Related]
33. [Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group]. Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; van Valen F; Burdach S; Winkelmann W; Jürgens J; Böcker W Verh Dtsch Ges Pathol; 1994; 78():214-9. PubMed ID: 7533989 [TBL] [Abstract][Full Text] [Related]
34. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222 [TBL] [Abstract][Full Text] [Related]
35. Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999. Rodriguez-Galindo C; Billups CA; Kun LE; Rao BN; Pratt CB; Merchant TE; Santana VM; Pappo AS Cancer; 2002 Jan; 94(2):561-9. PubMed ID: 11900241 [TBL] [Abstract][Full Text] [Related]
36. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes. Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446 [TBL] [Abstract][Full Text] [Related]
37. STAT3 is activated in a subset of the Ewing sarcoma family of tumours. Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269 [TBL] [Abstract][Full Text] [Related]
38. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Cheung IY; Feng Y; Danis K; Shukla N; Meyers P; Ladanyi M; Cheung NK Clin Cancer Res; 2007 Dec; 13(23):6978-83. PubMed ID: 18056173 [TBL] [Abstract][Full Text] [Related]
39. Ewing's sarcoma: a miracle drug waiting to happen? Longtin R J Natl Cancer Inst; 2003 Nov; 95(21):1574-6. PubMed ID: 14600088 [No Abstract] [Full Text] [Related]
40. Novel approaches for the management of patients with Ewing sarcoma. Avigad S; Yaniv I Future Oncol; 2006 Oct; 2(5):659-65. PubMed ID: 17026457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]